Lunsumio

Medicinal product

(Invented) name

Lunsumio

Active substance (s)

Mosunetuzumabas

Strength

5 mg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX25, mosunetuzumab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2022-06-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Flakone (0,5 ml) yra	0.5 ml
Mosunetuzumabas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119128	105233	1105233	flakonas	0,5 ml N1		Receptinis	EU/1/22/1649/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-03	Registruotas